about Details  Reusable Tray Serving Container Storage Food Refrigerator Tray Preservation Food Storage Containers


  1. Home
  2. about Details  Reusable Tray Serving Container Storage Food Refrigerator Tray Preservation
  1. facebook
  2. twitter
  3. linkedin
  4. pinterest
Details about   Reusable Preservation Tray Refrigerator Food Storage Container Serving Tray
Condition: New: A brand-new, unused, unopened, undamaged item in its original packaging (where packaging is Brand:

Unbranded

Material: Plastic Country/Region of Manufacture: China
Number of Items in Set: 1 Department: Kitchen
Shape: Rectangular Features: Adjustable
Size: 30x22.5x3.5cm MPN:

Does Not Apply

Type: Food Preservation Tray

























published on tue nov 09 2021

about Details  Reusable Tray Serving Container Storage Food Refrigerator Tray Preservation Food Storage Containers

gandhi, s., klein, j., robertson, a., pena-hernandez, m. a.,

about Details  Reusable Tray Serving Container Storage Food Refrigerator Tray Preservation Food Storage Containers

lin, m. j., roychoudhury, p., lu, p., fournier, j., ferguson, d., mohamed bakhash, s. a., muenker, m. c., srivathsan, a., wunder, e. a., kerantzas, n., wang, w., pyle, a., wilen, c. b., ogbuagu, o., greninger ,, a. l., iwasaki, a., schulz, w. l., ko, a. i.

sars-cov-2 remdesivir resistance mutations have been generated in vitro but have not been reported in patients receiving treatment with the antiviral agent. we present a case of an immunocompromised patient with acquired b-cell deficiency who developed an indolent, protracted course of sars-cov-2 infection. remdesivir therapy alleviated symptoms and produced a transient virologic response, but her course was complicated by recrudescence of high-grade viral shedding. whole genome sequencing identified a mutation, e802d, in the nsp12 rna-dependent rna polymerase which was not present in pre-treatment specimens. in vitro experiments demonstrated that the mutation conferred a ~6-fold increase in remdesivir ic50 but resulted in a fitness cost in the absence of remdesivir. sustained clinical and virologic response was achieved after treatment with casirivimab-imdevimab. although the fitness cost observed in vitro may limit the risk posed by e802d,

, this case illustrates the importance of monitoring for remdesivir resistance and the potential benefit of combinatorial therapies in immunocompromised patients with sars-cov-2 infection.

509
1.2k
EVGENIA.RU RSS